Literature DB >> 17180519

The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient.

Jaap de Boer1, Pieter L Jager, Theo Wiggers, Peter Nieboer, A N Machteld Wymenga, Elisabeth Pras, Klaas Hoogenberg, Dirk T Sleijfer, Albert J H Suurmeijer, Winette T A van der Graaf.   

Abstract

We report a patient with a nonresectable histologically benign solitary fibrous tumor who suffered from paraneoplastic non-islet cell tumor hypoglycemia (NICTH). Diagnostic workup revealed malignant characteristics in which the tumor showed up as, presumably, false-negative on fluorodeoxyglucose-positron emission tomography (FDG-PET), while being positive on tyrosine-PET. Neoadjuvant treatment, which consisted of combined chemo-radiation and consecutive selective embolization of the tumor feeding vessels, caused such a therapeutic effect, on both NICTH and reduction in tumor volume, that a secondary resection, with the patient in a normoglycemic status, was possible. Our report highlights several important issues in the management of the patient with a nonresectable solitary fibrous tumor with severe episodes of hypoglycemia due to NICTH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180519     DOI: 10.1007/s10147-006-0606-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  9 in total

1.  Tumor-induced hypoglycemia.

Authors:  D Le Roith
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Insulin-like growth factors and non-islet cell tumor hypoglycemia.

Authors:  L S Phillips; D G Robertson
Journal:  Metabolism       Date:  1993-09       Impact factor: 8.694

3.  Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.

Authors:  C D Fletcher; P Dal Cin; I de Wever; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van den Berghe; R Vanni; H Willén
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  Preoperative chemotherapy for soft-tissue sarcomas of the extremities.

Authors:  C M Pezzi; R E Pollock; H L Evans; J G Lorigan; T A Pezzi; R S Benjamin; M M Romsdahl
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

5.  Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.

Authors:  S R Grobmyer; R G Maki; G D Demetri; M Mazumdar; E Riedel; M F Brennan; S Singer
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

Review 6.  Radiolabeled amino acids: basic aspects and clinical applications in oncology.

Authors:  P L Jager; W Vaalburg; J Pruim; E G de Vries; K J Langen; D A Piers
Journal:  J Nucl Med       Date:  2001-03       Impact factor: 10.057

7.  Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH)

Authors:  J D Teale; V Marks
Journal:  Clin Endocrinol (Oxf)       Date:  1998-10       Impact factor: 3.478

Review 8.  The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.

Authors:  E Bastiaannet; H Groen; P L Jager; D C P Cobben; W T A van der Graaf; W Vaalburg; H J Hoekstra
Journal:  Cancer Treat Rev       Date:  2004-02       Impact factor: 12.111

Review 9.  Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone.

Authors:  M S Agus; L E Katz; M Satin-Smith; A T Meadows; R L Hintz; P Cohen
Journal:  J Pediatr       Date:  1995-09       Impact factor: 4.406

  9 in total
  17 in total

1.  Primary malignant cystic solitary fibrous tumour of the spleen.

Authors:  Rachel Maria Gomes; Dilip Kothari
Journal:  Indian J Surg Oncol       Date:  2012-09-29

2.  Metastatic solitary fibrous tumor of the pancreas in a patient with Doege-Potter syndrome.

Authors:  Xiaohui Qian; Dongkai Zhou; Bingqiang Gao; Weilin Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

3.  Two malignant solitary fibrous tumors in one kidney: Case report and review of the literature.

Authors:  Guangning Zhao; Gang Li; Ruifa Han
Journal:  Oncol Lett       Date:  2012-08-09       Impact factor: 2.967

4.  Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging.

Authors:  Mouhammed Amir Habra; Rodolfo Núñez; Hubert Chuang; Montserrat Ayala-Ramirez; Thereasa Rich; Karen Kyle; Camilo Jimenez
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

5.  Non-islet cell tumour hypoglycaemia.

Authors:  Leena Krishnan; John Clark
Journal:  BMJ Case Rep       Date:  2011-06-03

6.  Solitary fibrous tumor of the abdominal wall.

Authors:  Kazuhiro Migita; Akihiko Watanabe; Kenji Nakagawa; Takao Ohyama; Susumu Sekigawa
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

Review 7.  Management of non-islet-cell tumor hypoglycemia: a clinical review.

Authors:  Timothy W Bodnar; Maria J Acevedo; Massimo Pietropaolo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

8.  Solitary fibrous tumor.

Authors:  Andrea Bruzzone; Marco Varaldo; Claudia Ferrarazzo; Gianni Tunesi; Manlio Mencoboni
Journal:  Rare Tumors       Date:  2010-12-31

9.  Giant solitary fibrous tumor of the pelvis successfully treated with preoperative embolization and surgical resection: a case report.

Authors:  Yuichiro Yokoyama; Keisuke Hata; Takamitsu Kanazawa; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  World J Surg Oncol       Date:  2015-04-29       Impact factor: 2.754

Review 10.  Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome.

Authors:  Ahmed Y Kalebi; Martin J Hale; Michelle L Wong; Tessa Hoffman; Jill Murray
Journal:  J Cardiothorac Surg       Date:  2009-08-18       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.